Striking changes in anxiety in Huntington's disease transgenic mice

Brain Research

Volumn 805, Issue 1-2, 1998, Pages 234-240

  File, Sandra E ^a   Mahal, Amarbirpal ^a   Mangiarini, Laura ^a   Bates, Gillian P ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Anxiety; Benzodiazepine receptor; Exploration; Huntington's disease; Motor activity

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE RECEPTOR; FLUMAZENIL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; FEMALE; HUNTINGTON CHOREA; LOCOMOTION; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; ANXIETY; EXPLORATORY BEHAVIOR; FEMALE; FLUMAZENIL; HUNTINGTON DISEASE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; SPECIES SPECIFICITY;

EID: 0032517169     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00736-7     Document Type: Article

References (19)

1. G. Bates, Glutamine repeat expansions - a gain of insight, Bioessays 18 (1996) 175-178.
2. M.W. Becher, J.A. Kotzuk, A.H. Sharp, S.W. Davies, G.P. Bates, D.L. Price, C.A. Ross, Intranuclear neuronal inclusions in Huntington's disease and dentatorubral pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG repeat length, Neurobiol. Dis. 4 (1997) 1-11.
3. S.W. Davies, M. Turmaine, B. Cozens, M. DiFiglia, A.M. Sharp, C.A. Ross, E. Scherzinger, E.E. Wanker, L. Mangiarini, G.P. Bates, Formation of neuronal intranuclear inclusions (NII) underlies the neurological dysfunction in mice transgenic for the HD mutation, Cell 90 (1997) 537-548.
4. M. DiFiglia, E. Sapp, K.O. Chase, S.W. Davies, G.P. Bates, N. J.-P. Vonsattel, Aronin, aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain, Science 277 (1997) 1990-1993.
5. M. Duyao, C. Ambrose, R. Myers, A. Novelletto, F. Persichetti, M. Frontali, S. Folstein, C. Ross, M. Franz, M. Abbott, J. Gray, M.P. Conneally, A. Young, J. Penney, Z. Hollingsworth, I. Shoulson, A. Lazzarini, A. Falek, W. Koroshetz, D. Sax, E. Bird, J. Vonsattel, E. Bonilla, J. Alvir, J.B. Conde, J.-H. Cha, L. Dure, F. Gomez, M. Ramos, J. Sanchez-Ramos, S. Snodgrass, M. de Young, N. Wexler, C. Moscowitz, G. Penchaszadeh, H. MacFarlane, M. Anderson, B. Jenkins, J. Srinidhi, G. Barnes, J. Gusella, M. MacDonald, Trinucleotide repeat length instability and age of onset in Huntington's disease, Nature Genet. 4 (1993) 387-392.
6. S.E. File, The biological basis of anxiety, in: H.Y. Meltzer, D. Nerozzi (Eds.), Current Practices and Future Developments in the Pharmacotherapy of Mental Disorders, Excerpta Medica, Amsterdam, 1991, pp. 159-1661.
7. S.E. File, Behavioural detection of anxiolytic action, in: J.M. Elliott, D.J. Heal, C.A. Marsden (Eds.), Experimental Approaches to Anxiety and Depression, Wiley, Chichester, 1992, pp. 25-44.
8. S.E. File, A.G. Wardill, Validity of head-dipping as a measure of exploration in a modified holeboard, Psychopharmacologia (Berlin) 44 (1975) 53-59.
9. P.S. Harper, Huntington's Disease, Saunders, London, 1991.
10. Huntington's Disease Collaborative Research Group, A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes, Cell 72 (1993) 971-983.
11. M. Konig, A.M. Zimmer, H. Steiner, P.V. Holmes, J.N. Crawley, M.J. Brownstein, A. Zimmer, Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin, Nature 383 (1996) 535-538.
12. R.G. Lister, The use of a plus-maze to measure anxiety in the mouse, Psychopharmacology 92 (1987) 180-185.
13. L. Mangiarini, K. Sathasivam, A. Mahal, R. Mott, M. Seller, G.P. Bates, Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation, Nature Genet. 15 (1997) 197-200.
14. L. Mangiarini, K. Sathasivam, M. Seller, B. Cozens, A. Harper, C. Hetherington, M. Lawton, Y. Trottier, H. Lehrach, S.W. Davies, G.P. Bates, Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice, Cell 87 (1996) 493-506.
15. S. Pellow, P. Chopin, S.E. File, M. Briley, Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat, J. Neurosci. Methods 14 (1985) 149-167.
16. J. Rochford, S. Beaulieu, I. Rousse, J.R. Glowa, N. Barden, Behavioral reactivity to aversive stimuli in a transgenic mouse model of impaired glucocorticoid (type II) receptor function: effects of diazepam and FG-714, Psychopharmacology 132 (1997) 145-152.
17. L. Rondi-Reig, Y.L. Dubreuil, J.-C. Martinou, N. Delhaye-Bouchaud, J. Caston, J. Mariani, Fear decrease in transgenic mice over-expressing bcl-2 in neurons, NeuroReport 8 (1997) 2429-2432.
18. E. Scherzinger, R. Lurz, M. Turmaine, L. Mangiarini, B. Hollenbach, R. Hasenbank, G.P. Bates, S.W. Davies, H. Lehrach, E.E. Wanker, Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo, Cell 90 (1997) 549-558.
19. J.-P. Vonsattel, R.H. Myers, T.J. Stevens, R.J. Ferrante, E.D. Bird, E.P. Richardson, Neuropathological classification of Huntington's disease, J. Neuropathol. Exp. Neurol. 44 (1985) 559-577.